Drug intelligence / Profile preview

Nuteric

Development stage: Preclinical
Lead developer: Medosome Biotec
Administration: Oral

Overview

**Nuteric** is an orally administered therapeutic rehydration and anti-diarrheal solution being developed by Medosome Biotec for pediatric diarrhea. Medosome describes the product as designed to simultaneously reduce fluid loss and enhance rehydration; an ongoing clinical trial is reported in collaboration with icddr,b in Bangladesh. The precise active composition, molecular targets, and detailed pharmacologic mechanism have not been publicly specified.

Brand names: Nuteric

Beyond the preview

Go deeper on Nuteric.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nuteric.

Explore the full profile